Roghayyeh Saeedi
Overview
Explore the profile of Roghayyeh Saeedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
60
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khodaie F, Saeedi R, Soleimany G, Sahraian M, Kazemi A, Naser Moghadasi A, et al.
Chin J Integr Med
. 2025 Jan;
PMID: 39762502
Objective: To explore the effects of acupuncture in comparison with sham acupuncture on cognitive functions in patients with relapsing-remitting multiple sclerosis (RRMS). Methods: In this randomized controlled trial, 31 RRMS...
2.
Rezaeimanesh N, Abbasi Kasbi N, Saeedi R, Sahraian M, Jahromi S, Naser Moghadasi A
Endocrinol Diabetes Metab
. 2024 Oct;
7(6):e70006.
PMID: 39374429
Introduction: There has been a surge in interest in identifying the factors that impact cognitive impairment (CI) in patients with multiple sclerosis (MS). The purpose of our study was to...
3.
Rezaeimanesh N, Saeedi R, Sahraian M, Ghadiri F, Naser Moghadasi A
Curr J Neurol
. 2023 Nov;
21(2):74-82.
PMID: 38011484
Cognitive dysfunction is one of the problems that patients with neuromyelitis optica spectrum disorder (NMOSD) suffer from. We aimed to assess the association between demographic and clinical features as well...
4.
Razeghi-Jahromi S, Doosti R, Ghorbani Z, Saeedi R, Abolhasani M, Akbari N, et al.
Curr J Neurol
. 2023 Nov;
19(3):112-121.
PMID: 38011378
Among multiple sclerosis (MS) related symptoms and complications, fatigue might impact roughly 90% of patients. Decline in cognitive function is one of the other complications that occur in the first...
5.
Fattahi M, Iranmehr A, Saeedi R, Sahraian M, Doosti R, Naser Moghadasi A
Curr J Neurol
. 2023 Nov;
21(4):230-235.
PMID: 38011337
Despite special global considerations which have been made to prioritize vaccination of people with multiple sclerosis (MS), some are reluctant to get vaccinated. This study was aimed to evaluate the...
6.
Rezaeimanesh N, Rafiee P, Saeedi R, Khosravian P, Sahraian M, Eskandarieh S, et al.
Biometals
. 2023 Nov;
37(2):305-319.
PMID: 37917350
The prevalence of cognitive impairment in multiple sclerosis (MS) patients is estimated to be approximately 40-60%. There is an increasing body of evidence regarding the impact of both selenium and...
7.
Rezaeimanesh N, Rafiee P, Saeedi R, Eskandarieh S, Sahraian M, Khosravian P, et al.
Front Neurol
. 2023 May;
14:1126215.
PMID: 37122312
Introduction: Depression, fatigue, and anxiety are three common clinical comorbidities of multiple sclerosis (MS). We investigated the role of physical activity (PA) level and body mass index (BMI) as modifiable...
8.
Salehizadeh S, Saeedi R, Sahraian M, Rezaei Aliabadi H, Hashemi S, Eskandarieh S, et al.
Caspian J Intern Med
. 2022 Aug;
13(3):484-489.
PMID: 35974939
Background: The present study aimed to address the effect of Rituximab on the cognitive impairment in patients with secondary progressive MS (SPMS). Methods: The present interventional study used a convenience...
9.
Saeedi R, Rezaeimanesh N, Sahraian M, Naser Moghadasi A
Iran J Psychiatry
. 2021 Oct;
16(3):336-342.
PMID: 34616468
The prevalence of cognitive impairment in multiple sclerosis (MS) is significant and it is estimated that 40% to 70% of patients with MS suffer from this impairment. COVID-19 is also...
10.
Ghadiri F, Sahraian M, Saeedi R, Naser Moghadasi A
Mult Scler Relat Disord
. 2021 Jun;
53:103045.
PMID: 34102606
No abstract available.